Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.22%792M | -2.09%842M | -0.55%1.09B | -1.42%3.74B | 0.72%981M | -0.25%810M | -2.16%860M | -3.54%1.09B | -6.23%3.8B | -12.01%974M |
| Operating revenue | 0.26%762M | -1.11%804M | -0.10%1.05B | -1.68%3.56B | 0.21%940M | -0.52%760M | -3.33%813M | -2.78%1.05B | -6.58%3.62B | -12.01%938M |
| Cost of revenue | -2.98%228M | -7.64%254M | -9.57%312M | -6.86%1.14B | -6.23%286M | -12.31%235M | -1.08%275M | -7.75%345M | -6.77%1.23B | -18.88%305M |
| Gross profit | -1.91%564M | 0.51%588M | 3.62%773M | 1.17%2.6B | 3.89%695M | 5.70%575M | -2.66%585M | -1.45%746M | -5.96%2.57B | -8.48%669M |
| Operating expense | -28.18%339M | -12.53%356M | 7.24%311M | 0.52%1.56B | -28.02%316M | 27.91%472M | 7.96%407M | -21.20%290M | 10.85%1.55B | 61.99%439M |
| Selling and administrative expenses | 0.00%98M | -35.86%93M | 15.96%109M | 14.25%449M | 5.66%112M | -1.01%98M | 55.91%145M | -1.05%94M | 5.08%393M | 4.95%106M |
| -General and administrative expense | 0.00%98M | -35.86%93M | 15.96%109M | 14.25%449M | 5.66%112M | -1.01%98M | 55.91%145M | -1.05%94M | 5.08%393M | 4.95%106M |
| Depreciation amortization depletion | 3.98%183M | 2.25%182M | 2.84%181M | -1.93%711M | -14.22%181M | 4.14%176M | 0.56%178M | 4.76%176M | 12.93%725M | 21.26%211M |
| -Depreciation and amortization | 3.98%183M | 2.25%182M | 2.84%181M | -1.93%711M | -14.22%181M | 4.14%176M | 0.56%178M | 4.76%176M | 12.93%725M | 21.26%211M |
| Other taxes | -4.76%20M | 0.00%20M | 5.00%21M | 6.85%78M | 0.00%17M | 16.67%21M | 0.00%20M | 11.11%20M | 4.29%73M | 0.00%17M |
| Other operating expenses | -78.53%38M | -4.69%61M | ---- | -10.77%323M | -94.29%6M | 113.25%177M | -26.44%64M | -12.64%76M | 14.92%362M | 600.00%105M |
| Operating profit | 118.45%225M | 30.34%232M | 1.32%462M | 2.16%1.04B | 64.78%379M | -41.14%103M | -20.54%178M | 17.22%456M | -23.63%1.02B | -50.00%230M |
| Net non-operating interest income (expenses) | -3.67%-113M | -3.77%-110M | -4.72%-111M | -6.40%-432M | -5.71%-111M | -5.83%-109M | -4.95%-106M | -9.28%-106M | -9.43%-406M | -14.13%-105M |
| Non-operating interest income | -47.37%10M | -31.58%13M | -26.32%14M | 40.74%76M | 35.71%19M | 58.33%19M | 58.33%19M | 18.75%19M | 50.00%54M | -6.67%14M |
| Non-operating interest expense | -3.91%123M | -1.60%123M | 0.00%125M | 11.70%506M | 14.29%128M | 11.30%128M | 10.62%125M | 10.62%125M | 12.41%453M | 8.74%112M |
| Total other finance cost | ---- | ---- | ---- | -71.43%2M | ---- | ---- | ---- | ---- | 75.00%7M | ---- |
| Other net income (expenses) | -9.09%20M | 35.71%19M | -29.41%-44M | -94.72%16M | -156.88%-62M | -76.09%22M | 27.27%14M | -137.36%-34M | 344.35%303M | 161.24%109M |
| Gain on sale of security | -75.00%1M | ---- | -82.61%4M | -88.18%26M | -98.65%1M | -94.81%4M | 33.33%-2M | -68.06%23M | 233.33%220M | --74M |
| Special income (charges) | ---- | ---- | ---- | ---113M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --3M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of business | ---- | ---- | ---- | ---110M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | 9.21%-69M | 76.47%30M | ---- | ---- | ---- | ---76M | --17M | ---- |
| Income before tax | 725.00%132M | 63.95%141M | -2.85%307M | -31.80%624M | -11.97%206M | -90.24%16M | -35.82%86M | -17.49%316M | 9.19%915M | 23.16%234M |
| Income tax | 1,400.00%30M | 28.57%27M | -4.23%68M | -32.83%133M | -15.22%39M | -94.74%2M | -22.22%21M | -18.39%71M | -0.50%198M | 6.98%46M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 628.57%102M | 75.38%114M | -2.45%239M | -31.52%491M | -11.17%167M | -88.89%14M | -39.25%65M | -17.23%245M | 12.21%717M | 27.89%188M |
| Net income continuous operations | 628.57%102M | 75.38%114M | -2.45%239M | -31.52%491M | -11.17%167M | -88.89%14M | -39.25%65M | -17.23%245M | 12.21%717M | 27.89%188M |
| Noncontrolling interests | 0.00%2M | 0.00%3M | 0.00%3M | 10.00%11M | 0.00%3M | 100.00%2M | 50.00%3M | -25.00%3M | 42.86%10M | 50.00%3M |
| Net income attributable to the company | 733.33%100M | 79.03%111M | -2.48%236M | -32.11%480M | -11.35%164M | -90.40%12M | -40.95%62M | -17.12%242M | 11.87%707M | 27.59%185M |
| Preferred stock dividends | 0.00%20M | 0.00%19M | 0.00%19M | 0.00%77M | 0.00%19M | 0.00%20M | 0.00%19M | 0.00%19M | 2.67%77M | -5.00%19M |
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 1,100.00%80M | 113.95%92M | -2.69%217M | -36.03%403M | -12.65%145M | -107.62%-8M | -50.00%43M | -18.32%223M | 13.11%630M | 32.80%166M |
| Diluted earnings per share | 1,066.67%0.29 | 112.50%0.34 | -2.44%0.8 | -36.48%1.48 | -13.11%0.53 | -107.69%-0.03 | -50.00%0.16 | -18.81%0.82 | 12.56%2.33 | 32.61%0.61 |
| Basic earnings per share | 1,066.67%0.29 | 112.50%0.34 | -2.44%0.8 | -36.48%1.48 | -13.11%0.53 | -107.69%-0.03 | -50.00%0.16 | -18.81%0.82 | 13.11%2.33 | 32.61%0.61 |
| Dividend per share | 1.02%0.4577 | 1.02%0.4577 | 1.02%0.4577 | 1.00%1.8124 | 1.00%0.4531 | 1.00%0.4531 | 1.00%0.4531 | 1.00%0.4531 | 0.99%1.7944 | 0.99%0.4486 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.